Countries need to step up to end tuberculosis A declaration made by the G20 leaders during the 2017 Hamburg Summit acknowledged that there is a "growing threat to public health and economic growth" posed by antimicrobial resistance (AMR) [1] . Accordingly, a pledge was made to make AMR a priority for increased research and development; tuberculosis (TB) was highlighted as a particularly important issue.
policy broadly. There is thus a long way to go for decentralized TB care to become a reality in most settings.
India perfectly illustrates the shortcomings identified in the Out of Step report. Despite India accounting for approximately 27% of the world's new TB cases, and 29% of the TB deaths globally, TB has not received nearly enough funding, with health itself a low priority in the country [8, 9] . The Out of Step report shows that India is yet to widely scale-up tools such as the drugs bedaquiline and delamanid or Xpert MTB/RIF [4] . India also has yet to implement WHO policies on the shorter 9-month MDR-TB regimen and administer comprehensive latent TB therapy for high-risk populations [3] .
With such a compelling case made for a stronger response to what can only be described as a public health emergency, it is now up to us, patients, civil society, doctors, researchers, and TB controllers to come together and clamour for change. It is we who are to blame for our complacency and it is we who must stop settling for less, demand our governments for more [10] .
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